Using a hybrid, closed-loop insulin delivery system in the auto mode shows improved glycemic control and a favorable safety ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials ...

Cataract surgery is the most commonly performed eye surgery in the ophthalmology, with a track record of improving vision and ...

The ulcer grew. In fact, it seemed as though his leg was caving in as the flesh around it began rotting away. A month before ...

Amgen Inc. (NASDAQ: AMGN) is one of the. On June 23, the company announced full results from Part 1 of the Phase 2 study of ...

In the realm of diabetes management and diagnosis, two tests often come into focus: the fasting glucose test and the A1c test. Both are crucial tools in assessing blood sugar levels, but they serve ...

I read your recent column on A1C levels. You said that 7% to 7.5% was ideal for most people. For older people, you said 8% can be good. My longstanding understanding of A1C levels is that less than 5.

From detecting cancer and remote patient monitoring to streamlined documentation and automated prior authorizations, here are 15 proven clinical uses of AI — with results: ...

Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...

It can be hard to eat healthy without access to nutritious food in rural communities. Clemson Rural Health is trying to fix this problem.  7NEWS went to the Clemson ...